Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PetDx
AddedFeb 15, 2024
UpdatedJun 18, 2026
PetDx

PetDx

Series B

PetDx: A San Diego-based genomics firm offering liquid biopsy for early cancer detection in pets.

HQ
San Diego, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees

PetDx is a San Diego-based molecular diagnostics company focused on improving pet health through genomics. Their flagship product, OncoK9, is a multi-cancer early detection test for dogs, utilizing next-generation sequencing and proprietary bioinformatics algorithms to detect cancer from a simple blood draw.

PetDx has made significant strides in veterinary diagnostics, providing a non-invasive, early detection method for canine cancer. Their innovative approach has garnered attention and support within the veterinary community, positioning them as leaders in pet health genomics.

PetDx - Similar Companies

Oncotect logo

Oncotect

oncotect.co

Embark Veterinary logo

Embark Veterinary

embarkvet.com

FidoCure® logo

FidoCure®

fidocure.com

MySimplePetLab logo

MySimplePetLab

mysimplepetlab.com

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

Petsdx Veterinary Imaging logo

Petsdx Veterinary Imaging

petsdx.com

AOA Dx logo

AOA Dx

aoadx.com

Aeena Dx logo

Aeena Dx

Vetigenics logo

Vetigenics

vetigenics.com

Cadex Genomics logo

Cadex Genomics

cadexgenomics.com

Micronoma logo

Micronoma

micronoma.com

Liquid Genomics logo

Liquid Genomics

PepiPets logo

PepiPets

pepipets.com

Animal Life Sciences logo

Animal Life Sciences

CareDx logo

CareDx

caredx.com

PetDx - Quick Facts

Who are PetDx's competitors?

Companies similar to PetDx include Oncotect, Embark Veterinary, FidoCure® and MySimplePetLab.

When was PetDx founded?

PetDx was founded in 2019.

Where is PetDx's headquarters located?

PetDx's headquarters is located in San Diego, CA, US.

When was PetDx's last funding round?

PetDx's most recent funding round was for $62M (USD) in December 2021.

How much has PetDx raised to-date?

As of Dec 9, 2021, PetDx has raised a total of $72M (USD).

How many employees does PetDx have?

PetDx has 129 employees as of Feb 5, 2024.

PetDx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Genomics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Cancer Detection
Tags
  • Data Information
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified